Equities Analysts Offer Predictions for TSE:GUD Q4 Earnings
Knight Therapeutics Inc. (TSE:GUD – Free Report) – Analysts at Raymond James issued their Q4 2025 earnings per share estimates for Knight Therapeutics in a research note issued to investors on Thursday, March 20th. Raymond James analyst M. Freeman forecasts that the company will post earnings per share of $0.01 for the quarter. The consensus […]
Knight Therapeutics Inc. (TSE:GUD – Free Report) – Analysts at Raymond James issued their Q4 2025 earnings per share estimates for Knight Therapeutics in a research note issued to investors on Thursday, March 20th. Raymond James analyst M. Freeman forecasts that the company will post earnings per share of $0.01 for the quarter. The consensus […]
